Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 39: 2108-2114, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, H.
Right arrow Articles by Diamandis, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, H.
Right arrow Articles by Diamandis, E. P.

Clinical Chemistry, Vol 39, 2108-2114, Copyright © 1993 by American Association for Clinical Chemistry

Ultrasensitive time-resolved immunofluorometric assay of prostate- specific antigen in serum and preliminary clinical studies

H Yu and EP Diamandis
Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada.

We developed an ultrasensitive method for measuring prostate-specific antigen (PSA) in serum. The assay includes a capture monoclonal anti- PSA antibody coated to microtiter wells, a biotinylated rabbit polyclonal detection antibody, and alkaline phosphatase (ALP)-labeled streptavidin. The activity of ALP is measured with the substrate diflunisal phosphate; the released diflunisal forms highly fluorescent complexes with Tb(3+)-EDTA that are quantified with microsecond time- resolved fluorometry. The assay is precise and accurate and correlates well with the established Hybritech Tandem-PSA kit. Its distinguishing feature is extreme sensitivity (lowest limit of detection is 0.002 micrograms/L or 2 x 10(6) PSA molecules per assay). This is the most sensitive PSA assay reported thus far; we used it to quantify PSA in patients who had undergone radical prostatectomy. Many patients had < 0.01 micrograms/L PSA in their serum. This method could have important clinical applications in postsurgical early detection of relapse or residual prostate cancer, as recently suggested in the literature (Clin Chem 1992;38:1930-2).


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
C. V. Obiezu, S. J.C. Shan, A. Soosaipillai, L.-Y. Luo, L. Grass, G. Sotiropoulou, C. D. Petraki, P. A. Papanastasiou, M. A. Levesque, and E. P. Diamandis
Human Kallikrein 4: Quantitative Study in Tissues and Evidence for Its Secretion into Biological Fluids
Clin. Chem., August 1, 2005; 51(8): 1432 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Baumgart, A. Otto, A. Schafer, E. Usbeck, C. Cott, A. Schott, M. Tornack, A. Wenzel, A. Mossie, and G. Birkenmeier
Characterization of Novel Monoclonal Antibodies for Prostate-Specific Antigen (PSA) with Potency to Recognize PSA Bound to {alpha}2-Macroglobulin
Clin. Chem., January 1, 2005; 51(1): 84 - 92.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Kishi, A. Soosaipillai, L. Grass, S. P. Little, E. M. Johnstone, and E. P. Diamandis
Development of an Immunofluorometric Assay and Quantification of Human Kallikrein 7 in Tissue Extracts and Biological Fluids
Clin. Chem., April 1, 2004; 50(4): 709 - 716.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Borgono, L. Grass, A. Soosaipillai, G. M. Yousef, C. D. Petraki, D. H. C. Howarth, S. Fracchioli, D. Katsaros, and E. P. Diamandis
Human Kallikrein 14: A New Potential Biomarker for Ovarian and Breast Cancer
Cancer Res., December 15, 2003; 63(24): 9032 - 9041.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. M. Yousef, M.-E. Polymeris, L. Grass, A. Soosaipillai, P.-C. Chan, A. Scorilas, C. Borgono, N. Harbeck, B. Schmalfeldt, J. Dorn, et al.
Human Kallikrein 5: A Potential Novel Serum Biomarker for Breast and Ovarian Cancer
Cancer Res., July 15, 2003; 63(14): 3958 - 3965.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Kishi, L. Grass, A. Soosaipillai, A. Scorilas, N. Harbeck, B. Schmalfeldt, J. Dorn, M. Mysliwiec, M. Schmitt, and E. P. Diamandis
Human Kallikrein 8, a Novel Biomarker for Ovarian Carcinoma
Cancer Res., June 1, 2003; 63(11): 2771 - 2774.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Hutchinson, L.-Y. Luo, G. M. Yousef, A. Soosaipillai, and E. P. Diamandis
Purification of Human Kallikrein 6 from Biological Fluids and Identification of its Complex with {alpha}1-Antichymotrypsin
Clin. Chem., May 1, 2003; 49(5): 746 - 751.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Kishi, L. Grass, A. Soosaipillai, C. Shimizu-Okabe, and E. P. Diamandis
Human Kallikrein 8: Immunoassay Development and Identification in Tissue Extracts and Biological Fluids
Clin. Chem., January 1, 2003; 49(1): 87 - 96.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. V. Obiezu, A. Soosaipillai, K. Jung, C. Stephan, A. Scorilas, D. H. C. Howarth, and E. P. Diamandis
Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and Immunohistochemistry
Clin. Chem., August 1, 2002; 48(8): 1232 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. R. Grzeda, T. Le Bui, C. N. Warner, T. L. Pirucki, L. M. Dewey, M. Babich, and J. A. Maggiore
Measurement of Prostate-specific Antigen by Use of a Novel Blood Collection and Analytical System
Clin. Chem., August 1, 2002; 48(8): 1272 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Bulmer, G. Ward, E. Diamandis, D. Nicol, and J. Clements
Prostaglandin D Synthase Does Not Produce Prostate-specific Antigen Cross-Reactivity in Renal Cell Carcinoma
Clin. Chem., March 1, 2001; 47(3): 607 - 608.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
L.-Y. Luo, L. Grass, D. J.C. Howarth, P. Thibault, H. Ong, and E. P. Diamandis
Immunofluorometric Assay of Human Kallikrein 10 and Its Identification in Biological Fluids and Tissues
Clin. Chem., February 1, 2001; 47(2): 237 - 246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. L. Simone, A. T. Remaley, L. Charboneau, E. F. Petricoin III, J. W. Glickman, M. R. Emmert-Buck, T. A. Fleisher, and L. A. Liotta
Sensitive Immunoassay of Tissue Cell Proteins Procured by Laser Capture Microdissection
Am. J. Pathol., February 1, 2000; 156(2): 445 - 452.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. H.L. Chiu and T. K. Christopoulos
Two-Site Expression Immunoassay Using a Firefly Luciferase-coding DNA Label
Clin. Chem., November 1, 1999; 45(11): 1954 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. H. Black, C. L. Grass, J. Leinonen, U.-H. Stenman, and E. P. Diamandis
Characterization of Monoclonal Antibodies for Prostate-specific Antigen and Development of Highly Sensitive Free Prostate-specific Antigen Assays
Clin. Chem., March 1, 1999; 45(3): 347 - 354.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Lopez-Otin and E. P. Diamandis
Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
Endocr. Rev., August 1, 1998; 19(4): 365 - 396.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S.-F. Chen, Y. Xu, and M. P.-C. Ip
Electrochemical Enzyme Immunoassay for Serum Prostate-Specific Antigen at Low Concentrations
Clin. Chem., August 1, 1997; 43(8): 1459 - 1461.
[Full Text]


Home page
Clin. Chem.Home page
F. T. Kreutz and M. R. Suresh
Novel bispecific immunoprobe for rapid and sensitive detection of prostate-specific antigen
Clin. Chem., April 1, 1997; 43(4): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yu, E. P. Diamandis, M. Monne, and C. M. Croce
Oral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast
J. Biol. Chem., March 24, 1995; 270(12): 6615 - 6618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.